← Back
Data updated: Jun 28, 2026
CHEMO RESEARCH SL
Pharma Pharmaceuticals
CHEMO RESEARCH SL is a pharmaceutical company with 1 FDA-approved products.
2017
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
FDA Novel Drug Designations
(2017) 1 Novel 1 Orphan 1 Accelerated 1 Priority Review
See 1 novel approval →
CHEMO RESEARCH SL's Key Drugs
CHEMO RESEARCH SL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
CHEMO RESEARCH SL's Recent FDA Approvals
New NDA/BLA approvals for CHEMO RESEARCH SL over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
CHEMO RESEARCH SL's Therapeutic Areas
Disease areas where CHEMO RESEARCH SL has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CHEMO RESEARCH SL Pipeline Snapshot
Active clinical trials for CHEMO RESEARCH SL across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2017-08-29
- Latest
- 2021-12-15
- Applications
- 1